For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Relay Therapeutics Inc (NASDAQ: RLAY) was $4.50 for the day, down -7.02% from the previous closing price of $4.84. In other words, the price has decreased by -$7.02 from its previous closing price. On the day, 1.73 million shares were traded. RLAY stock price reached its highest trading level at $4.83 during the session, while it also had its lowest trading level at $4.475.
Ratios:
Our analysis of RLAY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 18.42 and its Current Ratio is at 18.42. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on September 10, 2024, Upgraded its rating to Buy and sets its target price to $16 from $10.60 previously.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 16 ’24 when THE PATEL FAMILY IRREVOCABLE U bought 100,000 shares for $5.00 per share.
Rahmer Peter sold 1,621 shares of RLAY for $9,823 on Oct 28 ’24. The insider now owns 390,063 shares after completing the transaction at $6.06 per share. On Oct 28 ’24, another insider, Catinazzo Thomas, who serves as the Chief Financial Officer of the company, sold 6,802 shares for $6.06 each. As a result, the insider received 41,220 and left with 306,391 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 753223552 and an Enterprise Value of -36570688. For the stock, the TTM Price-to-Sale (P/S) ratio is 75.25 while its Price-to-Book (P/B) ratio in mrq is 0.90. Its current Enterprise Value per Revenue stands at -3.655 whereas that against EBITDA is 0.094.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $12.14, while it has fallen to a 52-week low of $4.25. The 50-Day Moving Average of the stock is -18.94%, while the 200-Day Moving Average is calculated to be -34.50%.
Shares Statistics:
RLAY traded an average of 1.86M shares per day over the past three months and 3171150 shares per day over the past ten days. A total of 166.89M shares are outstanding, with a floating share count of 123.26M. Insiders hold about 26.36% of the company’s shares, while institutions hold 73.16% stake in the company. Shares short for RLAY as of 1732838400 were 11930533 with a Short Ratio of 6.41, compared to 1730332800 on 12043516. Therefore, it implies a Short% of Shares Outstanding of 11930533 and a Short% of Float of 8.649999999999999.